Long-term Safety and Efficacy Data with Inhaled Pirfenidone (AP01) in the ATLAS Open-label Extension Study Up to 240 Weeks

Tamera J. Corte, Sebastien Tilleux, Deepthi K. Nair, Felix A. Woodhead, Hao Bao, Craig S. Conoscenti, Howard M. Lazarus, Margaret L. Wilsher (2025). Poster presented at American Thoracic Society (ATS) Conference